Edwards Lifesciences Corp (EW) Peer Comparison

$94.91

$3.13 (3.40%)

As on 29-Oct-2026 15:44EDT

Market cap

$51,340 Mln

Revenue (TTM)

$6,512 Mln

P/E Ratio

53

P/B Ratio

4.8

Div. Yield

0 %

Edit

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Market cap ($ Mln)	51,340	250,149	179,441	161,511	159,784
Revenue ($ Mln)	6,512	47,351	48,229	25,608	11,578
Net Profit ($ Mln)	1,004.90	7,083.00	4,701.00	4,331.00	2,957.20
Net Margin (%)	15.43	14.96	9.75	16.91	25.54
RoE (%)	9.60	13.25	18.06	8.13	17.59
Price to Earnings	53.02	36.61	38.55	38.04	54.69
Price-To-Book	4.82	4.67	3.58	2.96	7.82

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Operating Revenue	6,512.30	47,351.00	48,229.00	25,608.00	11,578.00
Cost of Revenue	1,435.70	27,729.00	20,681.00	10,603.00	3,798.50
Gross Profit	4,740.70	18,239.00	24,607.00	14,970.00	6,642.30
Operating Expenses	3,248.70	11,106.00	20,197.00	9,787.00	4,495.40
Operating Profit (EBIT)	1,829.60	8,515.00	7,351.00	5,218.00	3,284.10
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	1,417.60	7,869.00	6,562.00	4,818.00	3,619.00
Provision for Tax	439.00	742.00	1,861.00	487.00	645.90
Profit after Tax (Net Income)	1,004.90	7,083.00	4,701.00	4,331.00	2,957.20
Minority Interest	1.30	-16.00	0.00	0.00	-14.30
Consolidated Profit	382.30	1,964.00	1,776.00	1,197.00	0.00

Liabilities ($ Mln)

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Shareholder's Funds	10,618.00	54,767.00	0.00	53,621.00	15,986.20
Minority Interest	1.30	-16.00	0.00	0.00	-14.30
Non-Current Liabilities	1,634.30	45,296.00	0.00	30,610.00	698.30
Current Liabilities	1,507.90	14,170.00	0.00	9,050.00	2,533.00
Total Liabilities	13,697.20	110,343.00	86,713.00	83,464.00	20,631.20

Assets ($ Mln)

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Non-Current Assets	7,048.20	88,618.00	0.00	78,494.00	10,920.80
Current Assets	6,818.90	25,615.00	0.00	14,787.00	8,428.30
Total Assets	13,697.20	110,343.00	86,713.00	83,464.00	20,631.20
Total Debt*	704.40	41,370.00	0.00	26,482.00	0.00
Net Current Assets	5,311.00	0.00	0.00	0.00	0.00

Cashflow ($ Mln)

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Cash From Operating Activities	1,595.20	7,818.00	9,566.00	6,416.00	3,030.50
Cash Flow from Investing Activities	-712.90	-4,047.00	-2,422.00	-1,196.00	665.80
Cash from Financing Activities	-956.80	1,801.00	-6,309.00	-2,961.00	-2,364.10
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
ROCE (%)	9.88	7.69	10.03	5.25	16.46
ROE (%)	9.60	13.25	18.06	8.13	17.59
ROA (%)	6.64	5.50	9.52	4.46	12.09
EBIT Margin (%)	21.76	13.63	11.82	15.27	24.79
Net Margin (%)	15.43	14.96	9.75	16.91	25.54
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Revenue Growth (%)	14.55	8.27	10.00	5.52	20.45
EBIT Growth (%)	-13.12	-24.37	-34.24	-12.03	-9.33
Net Profit Growth (%)	-75.75	7.81	-66.37	23.64	7.66
EPS Growth (%)	-75.16	9.68	-66.31	26.16	9.30
Book Value Growth (%)	2.48	9.37	--	6.02	-2.83

Valuation Ratios

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Price / Earnings	46.20	32.43	33.55	45.04	71.47
Price / Book Value	4.80	4.09	4.20	3.10	11.45
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	32.23	21.61	18.87	25.42	49.76
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Debt to Equity	0.06	0.00	0.29	0.00	0.00
Short term debt to equity ratio	0.00	0.04	0.06	0.04	0.00
Current Ratio	4.52	1.81	1.58	1.63	3.33
Quick Ratio	3.77	1.41	1.18	1.29	2.49
Interest Coverage	62.40	6.12	8.37	14.38	--

Operating Efficiency Ratios

	Edwards Lifesciences Corp (EW)	Thermo Fisher Scientific (TMO)	Abbott Laboratories (ABT)	Danaher (DHR)	Intuitive Surgical (ISRG)
Debtors to sales (%)	14.68	20.33	0.00	20.02	14.87
Asset Turnover	0.43	0.37	0.98	0.26	0.47
Receivable days	49.35	82.76	61.20	61.72	54.16
Inventory Days	304.57	72.19	117.44	91.69	177.54
Payable days	58.48	46.50	78.11	68.44	23.93
Cash Conversion Cycle	295.43	108.45	100.53	84.97	207.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly